Lycopene Enhances the Beta Cell Capacity and Antihyperlipidemic Effects of Metformin on Type 2 Diabetic Rats
Abstract
BACKGROUND: Hyperglycemia causes dyslipidemia in type 2 diabetes mellitus (T2DM). Metformin monotherapy is known to be less effective at improving glycemic status, insulin function, and lipid profiles. Lycopene is a potential antioxidant and has been shown to be hypoglycemic and hypocholesterolemic. However, the effects lycopene and metformin combination are still up for debate. This study was conducted to determine the potential of lycopene in enhancing the ability of metformin to improve glycemic status, insulin resistance, beta cell capacity, and lipid profile of T2DM rats.
METHODS: Thirty male Wistar rats were randomly divided into six groups: control (N), T2DM-untreated (D), T2DM + metformin (DM), T2DM + metformin + 10 mg/kgBW lycopene (DMLy-10), T2DM + metformin + 20 mg/kgBW lycopene (DMLy-20), and T2DM + metformin + 40 mg/kgBW lycopene (DMLy-40). The treatment was administered once daily through oral route and lasted for 28 days, before blood samples were collected. Fasting blood glucose (FBG) was assessed by oxidase-peroxidase method, fasting serum insulin and HbA1c were measured using enzyme-linked immunosorbent assay (ELISA), while lipid profile was determined using enzymatic methods. The homeostatic model assessment for insulin resistance (Homa-IR) as well as the homeostatic model evaluation of β-cell function (Homa-B) were then calculated.
RESULTS: Fasting serum insulin levels increased significantly (p<10.05) in the DMLy-20 and DMLy-40 groups, but Homa-B or high-density lipoprotein (HDL) did not significantly increase. Additionally, the FBG, HbA1c, Homa-IR, total cholesterol, triglyceride, and low-density lipoprotein levels were not significantly decreased than in the group treated with metformin alone.
CONCLUSION: Lycopene can enhance the ability of metformin to improve the glycemic status, insulin resistance, beta-cell capacity, and lipid profile of T2DM rats.
KEYWORDS: dyslipidemia, Homa-B, insulin resistance, lycopene, metformin, type 2 diabetes mellitus
Full Text:
PDFReferences
Dludla P V, Mabhida SE, Ziqubu K, Nkambule BB, Mazibuko-Mbeje SE, Hanser S, et al. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World J Diabetes. 2023; 14(3): 130–46, CrossRef.
Chen Z, Bai Y, Long X, Luo Q, Wen Z, Li Y, et al. Effects of adiponectin on T2DM and glucose homeostasis: A mendelian randomization study. Diabetes Metab Syndr Obes. 2020; 13: 1771–84, CrossRef.
Khalili D, Khayamzadeh M, Kohansal K, Ahanchi NS, Hasheminia M, Hadaegh F, et al. Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes? BMC Endocr Disord. 2023; 23(1): 39, CrossRef.
Khin PP, Lee JH, Jun HS. Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm. 2023; 21: 1–13, CrossRef.
Darmayanti S, Hendriani R, Sartika CR. The number and potential of endothelial progenitor cells in controlled group of type 2 diabetes mellitus patients are higher than the poorly controlled group. Indones Biomed J. 2019; 11(2): 205–9, CrossRef.
Berezin A. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Diabetes Metab Syndr Clin Res Rev. 2016; 10(2Suppl1): S176–83, CrossRef.
Sharma P, Singh S, Thakur V, Sharma N, Grewal AS. Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. Obes Med. 2021; 23(2): 100329, CrossRef.
American Diabetes Association. Standards of medical care in diabetes—2020 abridged for primary care providers. Clin Diabetes. 2020; 38(1): 10–38, CrossRef.
Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016; 101(4): 1754–61, CrossRef.
Flory JH, Mushlin AI. Effect of cost and formulation on persistence and adherence to initial metformin therapy for type 2 diabetes. Diabetes Care. 2020; 43(6): e66–7, CrossRef.
Kamel AM, Ismail B, Abdel Hafiz G, Sabry N, Farid S. Effect of metformin on oxidative stress and left ventricular geometry in nondiabetic heart failure patients: A randomized controlled trial. Metab Syndr Relat Disord. 2024; 22(1): 49–58, CrossRef.
Dhanasekara CS, Nelson A, Spradley M, Wynn A, Robohm-Leavitt C, Shen CL, et al. Effects of consumption of coconut oil or coconut on glycemic control and insulin sensitivity: A systematic review and meta-analysis of interventional trials. Nutr Metab Cardiovasc Dis. 2022; 32(1): 53–68, CrossRef.
Gillani SW, Ghayedi N, Roosta P, Seddigh P NO. Effect of metformin on lipid profiles of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. J Pharm Bioallied Sci. 2021; 13(1): 76–82, CrossRef.
Hu D, Guo Y, Wu R, Shao T, Long J, Yu B, et al. New insight into metformin-induced cholesterol-lowering effect crosstalk between glucose and cholesterol homeostasis via ChREBP (carbohydrate-responsive element-binding protein)-mediated PCSK9 (proprotein convertase subtilisin/kexin type 9) regulation. Arterioscler Thromb Vasc Biol. 2021; 41(4): e208–23, CrossRef.
Hedayati N, Oskouei Z, Tabeshpour J, Naeini MB. Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review. Eur J Pharmacol. 2021; 913: 174590, CrossRef.
Aligita W, Susilawati E, Sukmawati IK, Holidayanti L, Riswanti J. Antidiabetic activities of Muntingia calabura L. leaves water extract in type 2 diabetes mellitus animal models. Indones Biomed J. 2018; 10(2): 165–70, CrossRef.
Roxo DF, Arcaro CA, Gutierres VO, Costa MC, Oliveira JO, Lima TFO, et al. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats. Diabetol Metab Syndr. 2019; 11: 33, CrossRef.
Lestari K, Ridho A, Nurcayani N, Ramadhania ZM, Barliana MI. Stevia rebaudiana Bertoni leaves extract as a nutraceutical with hypoglycemic activity in diabetic rats. Indones Biomed J. 2019; 11(2): 182–7, CrossRef.
Guerra BA, Otton R. Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. Int Immunopharmacol. 2011; 11(12): 2220–6, CrossRef.
Gutierres VO, Assis RP AC. Curcumin improves the effect of a reduced insulin dose on glycemic control and oxidative stress in streptozotocin-diabetic rats. Phytother Res. 2019; 33(1): 976–88, CrossRef.
Lima TFO, Costa MC, Figueiredo ID, Inácio MD, Rodrigues MR, Assis RP, et al. Curcumin, alone or in combination with aminoguanidine, increases antioxidant defenses and glycation product detoxification in streptozotocin-diabetic rats: A therapeutic strategy to mitigate glycoxidative stress. Oxid Med Cell Longev. 2020; 2020: 1036360, CrossRef.
Leh HE, Mohd Sopian M, Abu Bakar MH, Lee LK. The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case–control study. Ann Med. 2021; 53(1): 1058–64, CrossRef.
Ugwor EI, James AS, Thomas FC, EstherA. Lycopene alleviates ionic disturbances and anaemia by improving iron homeostasis, insulin sensitivity, and ATPases activities in obese female rats. Obes Med. 2023; 41: 100502, CrossRef.
Yin Y, Zheng Z, Jiang Z. Effects of lycopene on metabolism of glycolipid in type 2 diabetic rats. Biomed Pharmacother. 2019; 109: 2070–7, CrossRef.
Zheng Z, Yin Y, Lu R, Jiang Z. Lycopene ameliorated oxidative stress and inflammation in type 2 diabetic rats. J Food Sci. 2019; 84(5): 1194–200, CrossRef.
Cheng HM, Koutsidis G, Lodge JK, Ashor AW, Siervo M, Lara J. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence. Crit Rev Food Sci Nutr. 2019; 59(1): 141–58, CrossRef.
Figueiredo ID, Lima TFO, Inácio MD, Costa MC, Assis RP, Brunetti IL, et al. Lycopene improves the metformin effects on glycemic control and decreases biomarkers of glycoxidative stress in diabetic rats. Diabetes Metab Syndr Obes. 2020; 13: 3117–35, CrossRef.
Haribabu T, Divakar K, Goli D. Evaluation of anti-diabetic activity of Lycopene and its synergistic effect with Metformin hydrochloride and Glipizide in Alloxan induced diabetes in rats. Sch Acad J Pharm. 2013; 2(2): 119–24, article.
Sianturi M, Susilaningsih N, Nugroho H, Suryani M. Lycopene improves the metformin effects on blood glucose and neutrophil counts in type 2 diabetic rats. Indones J Med Lab Sci Technol. 2023; 5(1): 80–9, CrossRef.
Motta BP, Pinheiro CG, Figueiredo ID, Cardoso FN, Oliveira JO, Machado RTA, et al. Combined effects of lycopene and metformin on decreasing oxidative stress by triggering endogenous antioxidant defenses in diet-induced obese mice. Molecules. 2022; 27(23): 8503, CrossRef.
Ejike DE, Adam MA, Sheu OS, Nganda P, Iliya E, Moses DA, et al. Lycopene attenuates diabetes-induced oxidative stress in Wistar rats. J Diabetes Endocrinol. 2018; 9(2): 11–9, CrossRef.
Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung. 2014; 101(4): 408–20, CrossRef.
Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 2014; 5(4): 349–58, CrossRef.
Husna F, Suyatna FD, Arozal W, Purwaningsih EH. Model hewan coba pada penelitian diabetes. Pharm Sci Res 2019; 6(3): 131–41, CrossRef.
Yoon H, Jeon DJ, Park CE, You HS, Moon AE. Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults. J Clin Biochem Nutr. 2016; 59(2): 139–44, CrossRef.
Willcox ML, Elugbaju C, Al-Anbaki M, Lown M, Graz B. Effectiveness of medicinal plants for glycaemic control in type 2 diabetes: An overview of meta-analyses of clinical trials. Front Pharmacol. 2021; 12: 777561, CrossRef.
Ahmad MF, Haidar MA, Naseem N, Ahsan H, Siddiqui WA. Hypoglycaemic, hypolipidaemic and antioxidant properties of Celastrus paniculatus seed extract in STZ-induced diabetic rats. Mol Cell Biomed Sci. 2023; 7(1): 10–7, CrossRef.
Sianturi M, Susilaningsih N, Nugroho H, Suci N, Kristina TN, Suryani M. Effect of lycopene and metformin combination on phagocytosis, glycemic control, and oxidative stress in rats with type 2 diabetes. Med J Indones. 2023; 32(1): 1–6, CrossRef.
Zhu R, Chen B, Bai Y, Miao T, Rui L, Zhang H, et al. Lycopene in protection against obesity and diabetes: A mechanistic review. Pharmacol Res. 2020: 159: 104966, CrossRef.
Zeng Z, He W, Jia Z, Hao S. Lycopene improves insulin sensitivity through inhibition of STAT3/Srebp-1c-mediated lipid accumulation and inflammation in mice fed a high-fat diet. Exp Clin Endocrinol Diabetes. 2017; 125(9): 610–7, CrossRef.
DOI: https://doi.org/10.18585/inabj.v16i3.2989
Copyright (c) 2024 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
